Vinge has advised Hansa Biopharma AB (publ). Hansa Biopharma AB (publ) has completed a directed share issue, raising approximately SEK 671.5 million before transaction costs. The...
Hansa Biopharma Completes SEK 671.5 Million Directed Share Issue
Azelio’s Preferential Rights Offering
Baker McKenzie advised Carnegie and Pareto Securities on the offering. Vinge has advised Azelio. Azelio AB executed a a fully guaranteed preferential rights issuance of approximately SEK...


























